Sell help not hope

Nature

Volumn 510, Issue 7505, 2014, Pages 336-337

  Bianco, Paolo ^a   Sipp, Douglas ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FOOD AND DRUG ADMINISTRATION; FREEDOM; HUMAN; MEDICAL PRACTICE; MEDICAL TECHNOLOGY; NOTE; PATIENT SAFETY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL; STEM CELL RESEARCH; TERMINALLY ILL PATIENT; UNITED STATES; ARTICLE; BIOLOGICAL THERAPY; BUSINESS ETHICS; ECONOMICS; ETHICS; GOVERNMENT REGULATION; LEGAL ASPECT; STANDARD; STEM CELL TRANSPLANTATION;

CELL- AND TISSUE-BASED THERAPY; ETHICS, BUSINESS; GOVERNMENT REGULATION; HUMANS; STEM CELL TRANSPLANTATION; TERMINALLY ILL;

EID: 84902952394     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/510336a     Document Type: Note

References (10)

1. von Eschenbach, A. 'Medical Innovation: How the US Can Retain its Lead' The Wall Street Journal (14 February 2012).
2. Gottlieb, S. & Klasmeier, C. 'The FDA Wants to Regulate Your Cells' The Wall Street Journal (7 August 2012).
3. Bianco, P. et al. EMBO J. 32, 1489-1495 (2013).
4. Caplan, A. I. & West, M. D. Stem Cells Transl. Med. 3, 560-563 (2014).
5. Hara, A., Sato, D. & Sahara, Y. Ther. Innov. Regul. Sci. http://dx.doi.org/10.1177/2168479014526877 (2014).
6. Allison, M. Nature Biotechnol. 30, 41-49 (2012).
7. London, A. J., Kimmelman, J. & Carlisle, B. Science 336, 544-545 (2012).
8. Sipp, D. Regen. Med. 7, 105-111 (2012).
9. Melchiorri, D. et al. Nature Rev. Drug Discov. 12, 719 (2013).
10. Mazzucato, M. The Entrepreneurial State: Debunking Public vs. Private Sector Myths (Anthem Press, 2013).